65--Radium-223 Dichloride-Nuclear Medicine- Indy VAMC

36C25019Q1365- NOTICE OF INTENT TO SOLE SOURCE Page 1 of 1 The VISN 10, Network Contracting Office (NCO 10) hereby gives notice of the Government s intent to establish a fixed-price contract action, commensurate with Public Law 102-585 pricing, consisting of a one (1) year base and four, one (1) year option with Cardinal Health Nuclear & Precision Health Solutions: 7000 Cardinal Place, Dublin, Ohio to acquire Xofigo (radium Ra-223 dichloride) injections, a pharmaceutical used to treat advanced prostate cancer. This contract action provides for filling all actual purchase requirements for providing Xofigo to treat patients receiving nuclear medicine services at the Richard L. Roudebush VA Medical Center: 1481 W. 10th Street, Indianapolis, IN, 46202. This contract action will be established IAW FAR 13.5. IAW FAR 13.501(a), this contract action will be established with a single source, Cardinal Health, because the original manufacturer of Xofigo, Bayer Healthcare Pharmaceuticals, has furnished documentation delegating Cardinal Health as the sole distributor for Xofigo. Additionally, Xofigo has been classified as a covered drug under the Pharmaceutical Pricing Agreement IAW Public Law 102-585. The assigned North American Industry Classification System (NAICS) code is 325412 and the Federal Supply Code (FSC) is 6505. Please do not request a copy of a solicitation. This notice is neither a request for competitive proposals, nor is it a solicitation of offers. Any response to this notice must demonstrate clear and convincing evidence that competition would be advantageous to the Government and any capability statement provided must address services listed above. Written communication received will be considered informational, and may be used as market research for determining procurement methods for future contract actions. If no affirmative written response is received on or before August 26, 2019, 1:00 PM EST, this contract action will be issued without further notice. No telephone inquiries will be accepted. Inquiries will only be accepted via email at [email protected]. A determination by the Government to not compete this requirement based on responses to this notice is solely within the discretion of the Government. THIS SYNOPSIS WILL BE USED TO SATISFY THE REQUIREMENT OF FAR 5.101; AND DOES NOT COMMIT THE GOVERNMENT TO CONTRACT FOR ANY SUPPLY OR SERVICE. THE GOVERNMENT WILL NOT PAY FOR ANY INFORMATION OR ADMINISTRATIVE COSTS INCURRED IN RESPONSE TO THIS SYNOPSIS.